You are here: Industry Insights > COVID-19

News List

Promising molecule for treatment of COVID-19 WorldPharmaNews
February 11, 2022
Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19.
New antiviral drug combo highly effective against coronavirus: Study ExpressPharma
February 11, 2022
The research, published recently in the journal Nature, suggests that these drugs are more potent when used in combination than individually.
Mandatory COVID-19 Tests Lifted for Vaccinated Travelers to Britain drugs.com
February 11, 2022
Vaccinated travelers will no longer have to take COVID-19 tests when they enter Britain, officials announced Friday.
FDA Grants Emergency Use Authorization for New Antibody Drug drugs.com
February 11, 2022
The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the Omicron variant.
U.S. Buys 600,000 Doses of New COVID-19 Treatment Still Awaiting FDA Approval drugs.com
February 11, 2022
The U.S. government has bought 600,000 doses of a new antibody drug called bebtelovimab that seems able to beat back the omicron...
FDA Postpones Decision on Pfizer COVID-19 Vaccine for Under 5s drugs.com
February 11, 2022
The U.S. Food and Drug Administration announced Friday that it will postpone an advisory panel meeting.
FDA Approves New Antibody Drug to Fight Omicron Variant drugs.com
February 11, 2022
The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the omicron variant.
Could COVID-19 vaccines be swallowed? EuropeanPharmaceuticalReview
February 10, 2022
New pre-clinical research demonstrates the potential of gastric autoinjectors to deliver mRNA in sufficient quantities for vaccination.
Glenmark and SaNOtize introduce nasal spray to treat Covid-19 in India Pharmaceutical-Technology
February 10, 2022
Earlier, Glenmark received manufacturing and marketing approval from the Drugs Controller General of India for NONS.
Pfizer reports 92% operational growth in full-year 2021 revenues Pharmaceutical-Technology
February 10, 2022
The company provided full year 2022 guidance for revenues in the range of $98bn to $102bn.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page